The purpose of this FOA is two-fold: (1) to advance identification of male-female differences in drug and alcohol research outcomes, to uncover the mechanisms of those differences, and to conduct translational research on those differences, and (2) to advance research specific to women or highly relevant to women.  Both preclinical and clinical studies are sought across all areas of drug and alcohol research.

Although this funding opportunity uses the R01 grant mechanism, it runs in parallel with two program announcements of identical scientific scope: PA-18-601, for R03 Small Grants, andPA-18-602, which uses the exploratory/developmental (R21) grant mechanism.

Deadlines:

• R01 Due Dates: Feb. 5, Jun. 5, Oct. 5
• R03 and R21 Due Dates: Feb. 16, Jun. 16, Oct. 16
• AIDS Due Dates: Jan. 7, May 7, Sep. 7

PA-18-603 Expiration Date May 8, 2021